Patient on anti-coagulant therapy Flashcards
(60 cards)
What is dabigatran?
Dabigatran is an oral anticoagulant that works by being a direct thrombin inhibitor. It is an alternative to warfarin and does not require regular monitoring.
What are the main indications for dabigatran?
Dabigatran is used for prophylaxis of venous thromboembolism following hip or knee replacement surgery and for prevention of stroke in patients with non-valvular atrial fibrillation.
What risk factors indicate the use of dabigatran for stroke prevention?
Risk factors include:
1. Previous stroke, transient ischaemic attack or systemic embolism
2. Left ventricular ejection fraction below 40%
3. Symptomatic heart failure of NYHA class 2 or above
4. Age 75 years or older
5. Age 65 years or older with diabetes mellitus, coronary artery disease or hypertension
What are the known side effects of dabigatran?
The major adverse effect of dabigatran is haemorrhage.
How should dabigatran dosing be adjusted in patients with kidney disease?
Doses should be reduced in chronic kidney disease and dabigatran should not be prescribed if the creatinine clearance is < 30 ml/min.
What is used for rapid reversal of dabigatran’s anticoagulant effects?
Idarucizumab can be used for rapid reversal of the anticoagulant effects of dabigatran.
What did the RE-ALIGN study reveal about dabigatran?
The RE-ALIGN study showed significantly higher bleeding and thrombotic events in patients with recent mechanical heart valve replacement using dabigatran compared with warfarin.
What is the current guidance regarding dabigatran use in patients with prosthetic heart valves?
Dabigatran is now contraindicated in patients with prosthetic heart valves.
What are direct oral anticoagulants (DOACs) used for?
DOACs are used for the prevention of stroke in non-valvular atrial fibrillation (AF), prevention of VTE following hip/knee surgery, and treatment of DVT and PE.
What risk factors are considered for stroke prevention in non-valvular AF with DOACs?
Risk factors include prior stroke or transient ischaemic attack, age 75 years or older, hypertension, diabetes mellitus, and heart failure.
What is the mechanism of action for Dabigatran?
Dabigatran is a direct thrombin inhibitor.
What is the mechanism of action for Rivaroxaban, Apixaban, and Edoxaban?
Rivaroxaban, Apixaban, and Edoxaban are direct factor Xa inhibitors.
How is Dabigatran primarily excreted?
Dabigatran is primarily excreted through the kidneys.
How is Rivaroxaban primarily excreted?
Rivaroxaban is primarily excreted through the liver.
How is Apixaban and Edoxaban primarily excreted?
Apixaban and Edoxaban are primarily excreted through feces.
What is the reversal agent for Dabigatran?
The reversal agent for Dabigatran is Idarucizumab.
What are the reversal agents for Rivaroxaban and Apixaban?
The reversal agents for Rivaroxaban and Apixaban are Andexanet alfa.
What are the two main types of heparin?
Unfractionated ‘standard’ heparin and low molecular weight heparin (LMWH).
How do heparins generally act?
By activating antithrombin III.
What does unfractionated heparin inhibit?
Thrombin, factors Xa, IXa, XIa, and XIIa.
What does LMWH primarily inhibit?
Factor Xa.
What are the adverse effects of heparins?
Bleeding, thrombocytopenia, osteoporosis, and hyperkalaemia.
What is a notable side effect of heparin related to potassium levels?
Hyperkalaemia, thought to be caused by inhibition of aldosterone secretion.
What is the administration route for standard heparin?
Intravenous.